benzodiazepine: be contraindicated in myasthenia gravis

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents sedative
Weight: 0.72
, medication
Weight: 0.70
, tranquilizer
Weight: 0.65
, depressant
Weight: 0.65
, compound
Weight: 0.56
Siblings temazepam
Weight: 0.73
, xanax
Weight: 0.64
, alprazolam
Weight: 0.61
, diazepam
Weight: 0.59
, phenobarbital
Weight: 0.38

Related properties

Property Similarity
be contraindicated in myasthenia gravis 1.00
be contraindicated in ptsd 0.96
be contraindicated in pregnancy 0.94
be contraindicated in porphyria 0.94
be contraindicated in glaucoma 0.92
be contraindicated in angle glaucoma 0.89
be contraindicated in narrow angle glaucoma 0.87
cause hypotension 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.64
Similarity weight: 0.94
Evidence: 0.46
¬ Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.79
¬ Remarkable(phenobarbital, be contraindicated in porphyria)

Remarkability from sibling implausibility

0.54
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.94
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.79
Remarkable(phenobarbital, be contraindicated in porphyria) ⋁
Evidence: 0.52
¬ Plausible(phenobarbital, be contraindicated in porphyria)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.72
¬ Salient(benzodiazepine, be contraindicated in myasthenia gravis)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.94
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.30
¬ Salient(benzodiazepine, be contraindicated in pregnancy)
0.70
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.46
Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.22
¬ Remarkable(benzodiazepine, be contraindicated in pregnancy)
0.70
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.42
¬ Plausible(benzodiazepine, be contraindicated in pregnancy)
0.70
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.81
Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.65
¬ Typical(benzodiazepine, be contraindicated in pregnancy)
0.68
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.92
Evidence: 0.81
Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.68
¬ Typical(benzodiazepine, be contraindicated in glaucoma)
0.68
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.96
Evidence: 0.81
Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.93
¬ Typical(benzodiazepine, be contraindicated in ptsd)
0.64
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.89
Evidence: 0.81
Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.81
¬ Typical(benzodiazepine, be contraindicated in angle glaucoma)
0.64
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.92
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.64
¬ Plausible(benzodiazepine, be contraindicated in glaucoma)
0.63
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.92
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.71
¬ Salient(benzodiazepine, be contraindicated in glaucoma)
0.63
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.87
Evidence: 0.81
Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.83
¬ Typical(benzodiazepine, be contraindicated in narrow angle glaucoma)
0.62
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.96
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.89
¬ Salient(benzodiazepine, be contraindicated in ptsd)
0.62
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.96
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.86
¬ Plausible(benzodiazepine, be contraindicated in ptsd)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.89
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.68
¬ Salient(benzodiazepine, be contraindicated in angle glaucoma)
0.61
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.89
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.69
¬ Plausible(benzodiazepine, be contraindicated in angle glaucoma)
0.60
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.78
Evidence: 0.81
Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.50
¬ Typical(benzodiazepine, cause hypotension)
0.60
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.96
Evidence: 0.46
Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.51
¬ Remarkable(benzodiazepine, be contraindicated in ptsd)
0.59
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.87
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.73
¬ Salient(benzodiazepine, be contraindicated in narrow angle glaucoma)
0.59
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.87
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.73
¬ Plausible(benzodiazepine, be contraindicated in narrow angle glaucoma)
0.59
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.89
Evidence: 0.46
Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.43
¬ Remarkable(benzodiazepine, be contraindicated in angle glaucoma)
0.56
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.87
Evidence: 0.46
Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.44
¬ Remarkable(benzodiazepine, be contraindicated in narrow angle glaucoma)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.56
¬ Plausible(benzodiazepine, cause hypotension)
0.53
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.78
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.72
¬ Salient(benzodiazepine, cause hypotension)
0.53
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.92
Evidence: 0.46
Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.60
¬ Remarkable(benzodiazepine, be contraindicated in glaucoma)
0.38
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.78
Evidence: 0.46
Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.79
¬ Remarkable(benzodiazepine, cause hypotension)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.72
Salient(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.81
¬ Typical(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.46
¬ Remarkable(benzodiazepine, be contraindicated in myasthenia gravis)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.71
Plausible(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.81
¬ Typical(benzodiazepine, be contraindicated in myasthenia gravis)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.94
Evidence: 0.46
¬ Remarkable(benzodiazepine, be contraindicated in myasthenia gravis) ⋁
Evidence: 0.46
¬ Typical(phenobarbital, be contraindicated in porphyria)